Press release
Global Biosimilars Market Size Growing at 24.7% CAGR, Set to Reach USD 143.6 Bn By 2031, Exclusive Report
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/162
Key Takeaways:
The biosimilars market has been experiencing significant growth in recent years. Biosimilars are highly similar versions of approved biologic drugs, offering comparable safety, efficacy, and quality to the reference products.
The primary driving factors behind the biosimilars market growth include the expiry of patents for several biologic drugs, increasing healthcare costs, and the need for affordable treatment options.
Biosimilars provide an opportunity for cost savings and improved access to essential therapies. They can potentially reduce healthcare expenditures by offering lower-priced alternatives to expensive biologics.
Regulatory frameworks have been established in various countries to ensure the safety and efficacy of biosimilars. These frameworks include stringent comparability studies and clinical trials to demonstrate biosimilarity to the reference product.
Market Drivers:
Patent Expirations: The expiration of patents for reference biologic drugs creates opportunities for biosimilar manufacturers to enter the market and offer more affordable alternatives.
Cost Savings: Biosimilars provide cost savings compared to their reference biologic drugs. As healthcare costs continue to rise, payers and healthcare providers are increasingly seeking cost-effective treatment options, driving the demand for biosimilars.
Increasing Demand for Biologics: Biologic drugs have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and chronic conditions. The increasing demand for these therapies creates a significant market opportunity for biosimilars.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/162
Competitive Landscape:
Pfizer Inc.
Novartis AG (Sandoz)
Amgen Inc.
Biocon Ltd.
Celltrion Inc.
Samsung Bioepis Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Fresenius Kabi AG
Dr. Reddy's Laboratories Ltd.
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/162
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Browse more latest healthcare reports:
Sperm Bank Market https://www.alliedmarketresearch.com/sperm-bank-market-A10372
Cancer Diagnostics Market https://www.alliedmarketresearch.com/cancer-diagnostics-market-A11336
Psoriatic Arthritis Treatment Market https://www.alliedmarketresearch.com/psoriatic-arthritis-treatment-market-A05951
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biosimilars Market Size Growing at 24.7% CAGR, Set to Reach USD 143.6 Bn By 2031, Exclusive Report here
News-ID: 3085158 • Views: …
More Releases from Allied Market Research
Waste Management Equipment Market to Reach $55.63 Billion by 2027, Expanding at …
Allied Market Research published a report titled, "Waste Management Equipment Market by Product Type, (Waste Disposal Equipment and Waste Recycling & Sorting Equipment), Waste Type (Hazardous and Non-hazardous), and Application (Industrial Waste, Municipal Waste, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027." According to the report, the global waste management equipment industry generated $ 45.75 billion in 2019, and is estimated to garner $55.63 billion by 2027, witnessing a…
Smart Packaging Market Poised for $38.6 Billion Valuation by 2030 as RFID and Se …
The global packaging industry is in the midst of a significant technological evolution, spearheaded by the rise of smart packaging. This innovative approach transcends the traditional function of containment and protection, transforming a product's wrapper into an intelligent system that provides real-time data and enhanced consumer interaction. The smart packaging market, which was valued at an impressive $22.25 billion in 2020, is on a steady trajectory of expansion. Forecasts predict…
Tools Market Outlook 2032: Worldwide Value to Climb to $153.2 Billion at 5.2% CA …
Allied Market Research published a report, titled "Tools Market Size by Category (Hand Tools, and Power Tools), Distribution Channel (In-Store, and Online), and End User (DIY, and Industrial & Commercial): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global tools industry generated $91.8 billion in 2022, and is anticipated to generate $153.2 billion by 2032, witnessing a CAGR of 5.2% from 2023 to 2032.
Download Sample Report…
Large Excavators Market to Reach $29.2 Billion Globally by 2032, Advancing at 3. …
Allied Market Research published a report, titled, "Large Excavators Market by Large Excavators Operating Weight (45 to 65 Tons, 65 to 100 tons, and Above 100 tons), Business Type (New Sales and Aftersales), and End User (Construction & Infrastructure, Mining & Quarrying, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global large excavators industry generated $21.9 billion in 2022, and is anticipated to generate…
More Releases for Biosimilars
Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes…
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Biosimilars Market Size During the Forecast Period?
The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,…
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth?
The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
